Skip to content

NEUROGEN

Active Private limited companyfounded 2001active for 25 yearsUyttenhovestraat 9, 1090 JetteKBO/BCE: BE 0474.427.988

Lifetime

20 annual accounts with figures on one time axis, 25 filings since 2001
peak of €95,387 in 2025
€95,387▲ 69.2%
lowest -€10,124 in 2016
€50,583▲ 140%
peak of €263,899 in 2025
€263,899▲ 11.4%
€41,528▲ 12.9%
Board3 names since 2011
3 directors and 2 others
Documentsfilings and deeds
02-06-202659 days before the deadline
2025micro format
Gross margin from €56,374 to €95,387Result from €21,067 to €50,583Dividend €23,500Cash from €117,548 to €38,384

Key points

from the 2025 annual accounts

Equity

€263,899 ▲ 11.4%

NEUROGEN has made a profit without a break since 2017.

Filings

25 annual accounts since 2001
AprilJune31 JulyOctober20102020

The last five annual accounts were filed 44 to 63 days before the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 31,390 companies had the same profile as NEUROGEN has now. Each dot stands for 79 companies, two years later.

93.4%
were still trading
6.0%
stopped another way
0.5%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 31,390 companies, not a prediction for NEUROGEN. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Director
Director
  • deed of 16-01-2014
  • deed of 16-01-2014
  • deed of 16-01-2014
Board & ownership

Recent changes

resigns as director General meeting of 09-06-2026 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0474427988
3 directors reappointed , and · General meeting of 06-12-2023 · Gazette deed
3 managers appointed, 3 resignations , and resign · , and appointed · General meeting of 04-05-2022 · Gazette deed
All 42 events

Comparable companies

same main activity, similar in size and age
Company
NEUROGEN Jette €305,427 €95,387 86.4% -
PIERRE POGORZELSKI Villers-le-Bouillet €321,893 €97,098 69.4% -
DR. BOLLEN ROSELYNE - HUISARTS Tongeren €338,810 €93,939 95.6% -
DOKTER GIE VANDERHEYDEN Antwerp €329,426 €95,969 99.1% -
MEDICALE DE LA CHEVRATTE Meix-devant-Virton €343,453 €98,085 76.0% -
DR. WIM DE BACKER Schelle €270,646 €90,445 98.3% -
DOCTEUR MOIJSES NATACHA Braine-le-Comte €266,265 €100,904 46.0% -

These companies have the same main activity as NEUROGEN: general medical practice (NACE 86210). They are comparable in size and age: total assets between €266,000 and €343,000, founded between 1998 and 2003.

Official details

Source: KBO
Status
Active since 28-03-2001Normal situation
Activity
General medical practiceNACE 86210
Establishment unit
2.098.046.3551090 Jette, since 04-05-2001
Financial year end
31 December
Peppol
Reachable since 02-12-2025
Company details

Annual accounts 2025

€305,427▲ 11.6%
Filing
Filed on 02-06-2026, 59 days before the end of the filing period
Financials

Insights on NEUROGEN

NEUROGEN files the micro format. That format states no turnover. The gross margin rose from €60,350 in 2006 to €95,387 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about NEUROGEN

What is the company number of NEUROGEN?
The company number of NEUROGEN is 0474.427.988. The VAT number is the same number with BE in front: BE 0474.427.988.
Where is NEUROGEN based?
The registered office is at Uyttenhovestraat 9, 1090 Jette.Company details
What does NEUROGEN do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of NEUROGEN?
NEUROGEN is a private limited company (BV).
When was NEUROGEN founded?
NEUROGEN was founded on 28-03-2001.
Is NEUROGEN still active?
Yes, NEUROGEN is an active enterprise in the KBO register.
What is the turnover of NEUROGEN?
The turnover of NEUROGEN was €399,937 in financial year 2025, according to the filed annual accounts.Financials
Is NEUROGEN profitable?
In financial year 2025, NEUROGEN made a profit of €50,583.
Where can I find the annual accounts of NEUROGEN?
NEUROGEN filed 25 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of NEUROGEN due?
NEUROGEN must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.